At a Glance
| 25E-NBOH | 1cP-AL-LAD | |
|---|---|---|
| Class | Psychedelic | Psychedelic |
| Routes | oral | |
| Effects | 51 documented | 72 documented |
| Interaction | Low Risk & Synergy | |
Dosage
Only in 1cP-AL-LAD
oral
| Level | Dose |
|---|---|
| Threshold | 20 µg |
| Light | 50–100 µg |
| Common | 100–225 µg |
| Strong | 225–350 µg |
| Heavy | 350 µg |
Duration
Only in 1cP-AL-LAD
oral
Total: 7 hrs – 10 hrsPeak
Offset
Afterglow
Onset20 min – 1 hrs
Come Up30 min – 1 hrs
Peak2.5 hrs – 5 hrs
Offset2 hrs – 3 hrs
Effects
Safety
Interaction: 25E-NBOH + 1cP-AL-LAD
Low Risk & Synergy
Cross-tolerance exists; effects compound
25E-NBOH — Dangerous Interactions
No dangerous interactions recorded.
1cP-AL-LAD — Dangerous Interactions
No dangerous interactions recorded.
Frequently Asked Questions
What is the difference between 25E-NBOH and 1cP-AL-LAD?
25E-NBOH is classified as a Psychedelic (Substituted phenethylamines) while 1cP-AL-LAD is classified as a Psychedelic (Lysergamides). They share 42 effects in common, with 9 effects unique to 25E-NBOH and 30 unique to 1cP-AL-LAD.
Is it safe to combine 25E-NBOH and 1cP-AL-LAD?
The interaction between 25E-NBOH and 1cP-AL-LAD is classified as "Low Risk & Synergy". Cross-tolerance exists; effects compound Always research interactions thoroughly before combining any substances.
Which is stronger, 25E-NBOH or 1cP-AL-LAD?
25E-NBOH and 1cP-AL-LAD are typically administered via different routes, making a direct potency comparison difficult. They belong to different pharmacological profiles and should not be compared by dose alone.